Pfizer: Neoplasms trials
The registry lists 103 Neoplasms studies with Pfizer as lead sponsor. 2 are open to participants now and 56 have results posted.
Phase 1 69Phase 2 20Phase 3 8Phase 4 2No phase 7(a study in two phases counts in both)
Studies
Page 2 of 2. Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Safety And Efficacy Study Of The Combination Of CpG 7909 And Herceptin In Patients With Metastatic Breast CancerCompletedNCT00031278Phase 1/2
- Study of SGN-15, Antibody-Drug Conjugate, to Treat Hormone Refractory Prostate CancerCompletedNCT00031187Phase 2
- A Comparison of Fluconazole and Amphotericin B in the Treatment of Fungal InfectionsCompletedNCT00002277Phase 3